로딩 중…
지수 로딩 중…
케이바이오
038530· KOSDAQ· Consumer Discretionary· Consumer Durables & Apparel
₩852-7.49%
2026-06-19
Price Chart
케이바이오-35.94%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 19.72B KRW |
| Revenue | 82.64B KRW |
| Net Income | -2.50B KRW |
| Total Assets | 119.04B KRW |
| Net Assets | 104.47B KRW |
| Employees | 33 |
| Value | |
| P/B | 0.19x |
| P/S | 0.24x |
| FCF Yield | 8.03% |
| Profitability | |
| ROE | -2.40% |
| ROA | -2.10% |
| Op. Margin | 0.45% |
| Revenue Growth | -22.75% |
| Financial Health | |
| Debt Ratio | 113.95% |
| FCF | 1.58B KRW |
| Cash | 28.09B KRW |
| Current Ratio | 5.84x |
| Net Debt/EBITDA | -75.36x |
| Performance | |
| 1Y Return | -35.94% |
| 1M Return | -30.45% |
| From 52W High | -69.02% |
| 1Y MDD | -66.98% |
| Trading | |
| Volume | 152,270 shares |
| Foreign Own. | 5.48% |
| Per Share | |
| EPS | -101 KRW |
| BPS | 2,330 KRW |
Company Info
K-Bio, established in 1997, expanded its business by acquiring CureBio's distribution division, adding a bio-distribution segment. The company operates two main businesses: distributing life science equipment and reagents, and developing video security equipment and ICT solutions. Leveraging agency contracts with global firms, K-Bio supplies products to universities and hospitals across Seoul and Gyeonggi. The company is actively developing and launching new IoT-based ICT products, including integrated control solutions and GIS MAP systems, from its headquarters in Gangdong-gu, Seoul.